Ipsen

We're hiring — explore open roles below and apply in a few clicks.

0 followers

www.ipsen.com/

Location

Headquarters: Boulogne-billancourt, Ile-de-France, France, Europe

Region: Ile-de-France

Country: FR

Continent: Europe

About

Ipsen is a global biopharmaceutical company dedicated to developing innovative specialty medicines for patients with high unmet medical needs. It focuses on three therapeutic pillars—oncology, rare diseases, and neuroscience—leveraging worldwide R&D, clinical trials, and partnerships to bring new treatments to market. Headquartered in France, Ipsen operates across the Americas, Europe, Asia‑Pacific, and the Middle East‑Africa.

Ipsen is a global biopharmaceutical company specializing in oncology, rare diseases, and neuroscience. It develops and markets specialty medicines to treat patients with high unmet medical needs across multiple therapeutic areas. The company operates in over 80 countries, leveraging research and development to deliver innovative treatments.

Legal Name:

Ipsen S.A.

Founded:

1929

Company Type:

for_profit

Operating Status:

active

Industries

Primary Industry: Business Services

PharmaceuticalsBusiness ServicesManagement ConsultingResearch & Development

Funding & Financials

Funding Stage:

Public Company

Total Funding:

304100000

Revenue:

over-1b

IPO Status:

ipo

Stock Symbol:

IPN.PA

Stock Exchange:

par

Investors

IpsenSR OneJohnson & JohnsonAbingworthSeventure PartnersLundbeckfonden VenturesEQT Life SciencesQuest for GrowthJohnson & Johnson Development Corporation

Founders

Henri Beaufour

Leadership

Elisabeth Vey — Analytical Development Leader

Sandra Silvestri — EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs

Philippe Lopes-Fernandes — Executive Vice President, Chief Business Officer, Member of the Executive Committee

Paul Murasko — Head of Digital Customer Interaction for North America

Aurélie Martin — Bioinformatics Engineer

Mike Patterson — Oncology Business Unit Head, Canada

Dominique Brard — Executive Vice President, Human Resources

Tim Bourque — Associate Director of Warehousing & Logistics

Saran Muthiah — advisor

Marc de Garidel — board_member

Peter Guenter — board_member

David Loew — board_member

JoëL Richard — board_member

Michele Ollier — board_member

Eric Ducamp — board_member

Technology Stack

HSTSDNSSECLetsEncryptnginxIPv6U.S. Server LocationHSTS IncludeSubdomains PreLoadWordPress 6.9Google CloudApple Mobile Web App Capable

Products

Cabometyx®: A treatment for advanced neuroendocrine tumors and certain cancers including kidney, liver, pancreas, thyroid, prostate, and breast cancers.

IQIRVO® (elafibranor): An investigational oral treatment for rare liver diseases, including primary biliary cholangitis and primary sclerosing cholangitis.

Dysport® (abobotulinumtoxinA): A botulinum toxin treatment for neuromuscular conditions including upper limb spasticity in children and adults.

Somatuline® Depot (lanreotide): An injectable treatment for neuroendocrine tumors and certain hormone-related disorders.